Silo Pharma (SILO) EBT (2018 - 2026)
Silo Pharma (SILO) posted EBT of -$1.6 million for Q1 2026, down 86.85% sequentially from -$881530.0 in Q4 2025, and down 59.69% YoY from -$4.1 million in Q1 2025.
Silo Pharma (SILO) EBT (2018 - 2026) Analysis & Trends
Silo Pharma has reported EBT for 9 years, with the latest figure at -$1.6 million in Q1 2026.
- Quarterly EBT fell 59.69% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (down 4.77% YoY) and the FY2025 annual result came in at -$4.2 million, up 3.76% from the prior year.
- EBT fell to -$1.6 million in Q1 2026 per SILO's latest filing, from -$881530.0 in the prior quarter.
- Over five years, EBT peaked at -$602909.0 in Q1 2022 and troughed at -$1.7 million in Q4 2024.
- A 5-year average of -$1.0 million and a median of -$983246.0 in 2022 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2025: EBT tumbled 115.15% in 2022, then soared 49.06% in 2025.
- Over 5 years, EBT stood at -$1.7 million in 2022, then surged by 36.76% to -$1.1 million in 2023, then plunged by 64.57% to -$1.7 million in 2024, then jumped by 49.06% to -$881530.0 in 2025, then tumbled by 86.85% to -$1.6 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$1.6 million, -$881530.0, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 81.49 Mn |
| 10 | Silo Pharma | 2.94 Mn | 2.94 Mn | - | -832,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -832,829.00 |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | -881,530.00 |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.20 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Sep 30, 2024 | -928,814.00 |
| Jun 30, 2024 | -931,779.00 |
| Mar 31, 2024 | -801,667.00 |
| Dec 31, 2023 | -1.05 Mn |
| Sep 30, 2023 | -660,160.00 |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -906,396.00 |
| Dec 31, 2022 | -1.66 Mn |
| Sep 30, 2022 | -983,246.00 |
| Jun 30, 2022 | -658,402.00 |
| Mar 31, 2022 | -602,909.00 |
| Dec 31, 2021 | -1.06 Mn |
| Sep 30, 2021 | 6.49 Mn |